Search results for " transplantation."

showing 10 items of 1389 documents

Longterm Survival After Liver Transplantation for Autoimmune Hepatitis : Results From the European Liver Transplant Registry

2020

The aim of this study was to analyze longterm patient and graft survival after liver transplantation for autoimmune hepatitis (AIH-LT) from the prospective multicenter European Liver Transplant Registry. Patient and liver graft survival between 1998 and 2017 were analyzed. Patients after AIH-LT (n = 2515) were compared with patients receiving LT for primary biliary cholangitis (PBC-LT; n = 3733), primary sclerosing cholangitis (PSC-LT; n = 5155), and alcohol-related cirrhosis (AC-LT; n = 19,567). After AIH-LT, patient survival was 79.4%, 70.8%, and 60.3% and graft survival was 73.2%, 63.4%, and 50.9% after 5, 10, and 15 years of follow-up. Overall patient survival was similar to patients af…

medicine.medical_specialtyCirrhosismedicine.medical_treatmentCholangitis SclerosingMedizinAutoimmune hepatitis030230 surgeryLiver transplantationGastroenterologyPrimary sclerosing cholangitis03 medical and health sciences0302 clinical medicineInternal medicinemedicineLiving DonorsHumansProspective StudiesRegistriesTransplantationHepatologybusiness.industryLiver Cirrhosis BiliaryHazard ratioPatient survivalmedicine.diseasedigestive system diseasesLiver TransplantationHepatitis AutoimmuneIncreased risk030211 gastroenterology & hepatologySurgeryGraft survivalbusiness
researchProduct

Changing delta hepatitis patient profile: A single center experience in Valencia region, Spain

2020

Background Delta hepatitis is a rare infection with an aggressive disease course. For almost three decades, however, there have been no epidemiological studies in our traditionally endemic area. Aim To investigate the prevalence of delta hepatitis in a sample of patients with chronic hepatitis B virus (HBV) infection followed at a Hepatology Unit in Valencia, Spain. Methods Retrospective evaluation of anti-hepatitis D virus-immunoglobulin G seroprevalence among patients with chronic HBV infection (n = 605) followed at a reference Hepatology Unit in Spain. Results The prevalence of anti-hepatitis D virus-immunoglobulin G among HBV-infected patients was 11.5%: Male (63%) and median age of 52 …

medicine.medical_specialtyCirrhosismedicine.medical_treatmentImmigrationLiver transplantation03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusEpidemiologymedicineSeroprevalenceViral hepatitisLiver transplantationHepatologybusiness.industryDelta hepatitisCase Control StudyHepatologymedicine.diseaseCirrhosis030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyValenciaViral hepatitisbusinessWorld Journal of Hepatology
researchProduct

Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the …

2018

Summary Cytomegalovirus is one of the most important infections to occur after allogeneic haematopoietic stem cell transplantation (HSCT), and an increasing number of reports indicate that cytomegalovirus is also a potentially important pathogen in patients treated with recently introduced drugs for hematological malignancies. Expert recommendations have been produced by the 2017 European Conference on Infections in Leukaemia (ECIL 7) after a review of the literature on the diagnosis and management of cytomegalovirus in patients after HSCT and in patients receiving other types of therapy for haematological malignancies. These recommendations cover diagnosis, preventive strategies such as pr…

medicine.medical_specialtyCongenital cytomegalovirus infectionCytomegalovirusAntiviral AgentsLetermovirInternal medicinemedicineHumansIn patientGanciclovirLeukemiabusiness.industryHematopoietic Stem Cell TransplantationMaribavirmedicine.diseaseTransplantationClinical trialHaematopoiesisInfectious DiseasesHematologic NeoplasmsCytomegalovirus InfectionsPractice Guidelines as TopicBenzimidazolesRibonucleosidesStem cellbusinessmedicine.drugThe Lancet. Infectious diseases
researchProduct

Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

2016

Cytomegalovirus (CMV) infection remains a major complication of solid organ transplantation. Because of management of CMV is variable among transplant centers, in 2011 the Spanish Transplantation Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) developed consensus guidelines for the prevention and treatment of CMV infection in solid organ transplant recipients. Since then, new publications have clarified or questioned the aspects covered in the previous document. For that reason, a panel of experts revised the evidence on CMV management, including immunological monitoring, diagnostics, prevention, vaccines, indirect effects, tre…

medicine.medical_specialtyCongenital cytomegalovirus infectionMEDLINEDrug resistance030230 surgeryAntiviral AgentsOrgan transplantation03 medical and health sciences0302 clinical medicineMonitoring ImmunologicMedicineHumansMajor complicationIntensive care medicineTransplantationbusiness.industryOrgan Transplantationmedicine.diseaseTransplant RecipientsCytomegalovirus infectionClinical microbiologyImmunologyCytomegalovirus InfectionsPractice Guidelines as Topic030211 gastroenterology & hepatologybusinessSolid organ transplantationTransplantation reviews (Orlando, Fla.)
researchProduct

Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutane…

2014

Background Histopathological diagnosis including selection of lesions, the determination of the best point of time for biopsy and workup is not trivial in cutaneous graft-versus-host disease (GvHD). Objectives To develop interdisciplinary recommendations on performing, the laboratory work up and reporting of the results of skin biopsies in patients with suspected cutaneous GvHD. Methods A working group consisting of dermatopathologists, dermatologists, transplant-physicians and transplant-pathologists prepared recommendations for performing skin biopsies, laboratory workup and evaluation of tissue samples, and reporting of the results in patients with cutaneous GvHD. After achieving a conse…

medicine.medical_specialtyConsensusBiopsymedicine.medical_treatmentMedizinGraft vs Host DiseaseDermatologyDiseaseSkin Diseasesimmune system diseasesSurveys and QuestionnairesBiopsyHumansTransplantation HomologousMedicineIn patientSkinintegumentary systemmedicine.diagnostic_testbusiness.industryHistological TechniquesHematopoietic Stem Cell TransplantationImmunosuppressionCutaneous graft-versus-host diseaseDermatologyWork-upSurgeryTransplantationsurgical procedures operativeInfectious DiseasesAcute DiseaseChronic DiseaseSkin biopsybusiness
researchProduct

Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study

2013

AIM: To investigate clinical and biochemical features of hepatorenal syndrome (HRS), to assess short and long-term survival evaluating potential predictors of early mortality. METHODS: Sixty-two patients with liver cirrhosis and renal failure, defined as a serum creatinine value > 1.5 mg/dL on at least two measurements within 48 h, admitted to our tertiary referral Unit from 2001 to 201, were retrospectively reviewed. Among them, 33 patients (53.2%) fulfilled the revised criteria of the International Ascites Club for the diagnosis of HRS. Twenty-eight patients were treated with combinations of terlipressin and albumin, two with dopamine and albumin, and three with albumin alone. No patients…

medicine.medical_specialtyCreatinineUnivariate analysisCirrhosisHepatologybusiness.industrymedicine.medical_treatmentLiver transplantationmedicine.diseaseGastroenterologySurgerychemistry.chemical_compoundLiver diseasechemistryHepatorenal syndromeInternal medicineAscitesmedicineOriginal Articlemedicine.symptomTerlipressinbusinesshepatorenal syndromemedicine.drug
researchProduct

Neural Networks Ensemble for Cyclosporine Concentration Monitoring

2001

This paper proposes the use of neural networks ensemble for predicting the cyclosporine A (CyA)concen tration in kidney transplant patients. In order to optimize clinical outcomes and to reduce the cost associated with patient care, accurate prediction of CyA concentrations is the main objective of therapeutic drug monitoring. Thirty-two renal allograft patients and different factors (age, weight, gender, creatinine and post-transplantation days, together with past dosages and concentrations)w ere studied to obtain the best models. Three kinds of networks (multilayer perceptron, FIR network, Elman recurrent network) and the formation of neural-network ensembles were used. The FIR network, y…

medicine.medical_specialtyCreatininemedicine.diagnostic_testArtificial neural networkComputer sciencebusiness.industryUrologyCiclosporinmedicine.diseaseMachine learningcomputer.software_genreKidney transplantchemistry.chemical_compoundchemistryTherapeutic drug monitoringMultilayer perceptronmedicineRenal allograftArtificial intelligencebusinesscomputerKidney transplantationmedicine.drug
researchProduct

P275 Clinical characteristics, associated malignancies and management of primary sclerosing colangitis in inflammatory bowel disease patients: A Span…

2018

medicine.medical_specialtyCrohn's diseasemedicine.diagnostic_testbusiness.industryColorectal cancermedicine.medical_treatmentGastroenterologyColonoscopyGeneral MedicineJaundiceLiver transplantationmedicine.diseaseUlcerative colitisInflammatory bowel diseaseTransplantation03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisInternal medicineMedicine030211 gastroenterology & hepatologymedicine.symptombusinessJournal of Crohn's and Colitis
researchProduct

Oral health-related quality of life of patients after solid organ transplantation is not affected by oral conditions:results of a multicentre cross-s…

2020

Background This multicentre cross-sectional study aimed in examination of oral health-related quality of life (OHRQoL) of patients after solid organ transplantation (SOT). Material and Methods Patients after SOT (liver, lung and heart) at one out of three German centers (Goettingen, Essen, Leipzig) were included. For comparison, a healthy control (HC) was recruited. OHRQoL was assessed by German short form of oral health impact profile (OHIP G14). Oral examination comprised: decayed-, missing- and filled-teeth index (DMF-T), remaining teeth and periodontitis severity. Results In total, 196 patients after SOT and 130 HC with comparable age, gender and smoking habits were included (p>0.05). D…

medicine.medical_specialtyCross-sectional studycell free dnaOral HealthOral healthIndependent predictororal lichen planusQuality of lifeSurveys and QuestionnairesInternal medicineHealthy controlmedicineHumansGeneral DentistryUNESCO:CIENCIAS MÉDICASPeriodontitissalivabusiness.industryResearchOrgan Transplantationoral cancerMedically compromised patients in Dentistrymedicine.diseasehumanitiesstomatognathic diseasesCross-Sectional StudiesOtorhinolaryngologyleukoplakiaQuality of LifeOral examinationSurgerySolid organ transplantationbusinessdna integrity index
researchProduct

Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with acute lymphoblastic leukemi…

2014

Abstract Total-body-irradiation (TBI) based preparative regimens are considered as standard conditioning therapy for allogeneic stem cell transplantation (AHSC) in patients with acute lymphoblastic leukemia (ALL). Within a multi-center prospective phase II study we have investigated the toxicity and efficacy of a non-TBI-based regimen consisting of treosulfan, etoposide, and cyclophosphamide in patients with ALL. Inclusion criteria were complete remission, non-eligibility for TBI or patient’s wish to avoid TBI. Between July 2007 and August 2010, 50 patients with a median age of 46.5 years were enrolled at ten German centers. 74% of the patients were in 1. CR and 26% 2. or higher CR.The cond…

medicine.medical_specialtyCyclophosphamidebusiness.industrymedicine.medical_treatmentImmunologyPhases of clinical researchCell BiologyHematologyHematopoietic stem cell transplantationTreosulfanBiochemistrySurgeryTransplantationRegimenInternal medicinemedicineCumulative incidencebusinessEtoposidemedicine.drug
researchProduct